Viveka Frykman-Kull

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2023;12(21):e030456
Short-Term Ambient Air Pollution Exposure and Risk of Out-of-Hospital Cardiac Arrest in Sweden: A Nationwide Case-Crossover Study
Dahlquist M; Frykman V; Hollenberg J; Jonsson M; Stafoggia M; Wellenius GA; Ljungman PLS
Article: ANNALS OF NONINVASIVE ELECTROCARDIOLOGY. 2023;28(4):e13067
Prognostic impact of morphology and duration of premature ventricular contractions in a population without structural heart disease
Scorza R; Jonsson M; Corander J-M; Rosenqvist M; Frykman V
Article: EUROPACE. 2023;25(2):517-525
Prognostic implication of premature ventricular contractions in patients without structural heart disease
Scorza R; Jonsson M; Friberg L; Rosenqvist M; Frykman V
Article: EUROPEAN HEART JOURNAL. 2023;44(3):196-204
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
Lyth J; Svennberg E; Bernfort L; Aronsson M; Frykman V; Al-Khalili F; Friberg L; Rosenqvist M; Engdahl J; Levin L-A
Article: PREVENTIVE MEDICINE. 2022;164:107284
Factors predicting participation and potential yield of screening-detected disease among non-participants in a Swedish population-based atrial fibrillation screening study
Gudmundsdottir KK; Bonander C; Hygrell T; Svennberg E; Frykman V; Stromberg U; Engdahl J
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY: HEART & VASCULATURE. 2022;42:101124
Evaluation of patients with high burden of premature ventricular contractions by comprehensive transthoracic echocardiography
Scorza R; Shahgaldi K; Rosenqvist M; Frykman V
Article: ENVIRONMENTAL EPIDEMIOLOGY. 2022;6(4):e215
Short-term ambient air pollution exposure and risk of atrial fibrillation in patients with intracardiac devices
Dahlquist M; Frykman V; Stafoggia M; Qvarnstrom E; Wellenius GA; Ljungman PLS
Article: THE LANCET. 2021;398(10310):1498-1506
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial
Svennberg E; Friberg L; Frykman V; Al-Khalili F; Engdahl J; Rosenqvist M
Article: DIAGNOSTICS. 2021;11(8):1505
Magnetic Resonance Detects Structural Heart Disease in Patients with Frequent Ventricular Ectopy and Normal Echocardiographic Findings
Scorza R; Jansson A; Sorensson P; Rosenqvist M; Frykman V
Article: JOURNAL OF ELECTROCARDIOLOGY. 2021;67:33-38
Progression and clinical manifestations in screening-detected atrial fibrillation: A follow-up of the STROKESTOP study
Liljegren F; Svennberg E; Frykman V; Engdahl J
Article: CLINICAL CARDIOLOGY. 2021;44(5):692-698
Performance of pulse palpation compared to one-lead ECG in atrial fibrillation screening
Gudmundsdottir KK; Fredriksson T; Svennberg E; Al-Khalili F; Friberg L; Habel H; Frykman V; Engdahl J
Article: ENVIRONMENT INTERNATIONAL. 2020;141:105765
Short-term associations between ambient air pollution and acute atrial fibrillation episodes
Dahlquist M; Frykman V; Kemp-Gudmunsdottir K; Svennberg E; Wellenius GA; Ljungman PLS
Article: BMC CARDIOVASCULAR DISORDERS. 2020;20(1):167
Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study
Fredriksson T; Gudmundsdottir KK; Frykman V; Friberg L; Al-Khalili F; Engdahl J; Svennberg E
Article: CLINICAL CARDIOLOGY. 2020;43(4):355-362
Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation-Compliance and ease of use in an ambulatory elderly population
Fredriksson T; Gudmundsdottir KK; Frykman V; Friberg L; Al-Khalili F; Engdahl J; Svennberg E
Article: EUROPACE. 2020;22(1):24-32
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
Gudmundsdottir KK; Fredriksson T; Svennberg E; Al-Khalili F; Friberg L; Frykman V; Hijazi Z; Rosenqvist M; Engdahl J
Article: OPEN HEART. 2020;7(1):e001200
Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels
Al-Khalili F; Kemp-Gudmundsdottir K; Svennberg E; Fredriksson T; Frykman V; Friberg L; Rosenqvist M; Engdahl J
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;291:57-62
Deactivation of implantable defibrillators at end of life - Can we do better?
Kinch Westerdahl A; Magnsjö J; Frykman V
Article: OPEN HEART. 2019;6(2):e001053
Does stress echocardiography add incremental value to baseline ejection fraction for the early identification of candidates for implantable defibrillators?
Muhrbeck J; Gunyeli E; Andersson E; Alam M; Frykman V; Sjoblom J
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2018;122(7):1179-1184
Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial Fibrillation
Fredriksson T; Frykman V; Friberg L; Al-Khalili F; Engdahl J; Svennberg E
Article: BRITISH JOURNAL OF SURGERY. 2018;105(3):279-286
All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism
Giesecke P; Frykman V; Wallin G; Lonn S; Discacciati A; Torring O; Rosenqvist M
Article: EUROPACE. 2017;19(10):1650-1656
Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis
Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Levin L-A
Article: EUROPACE. 2017;19(9):1449-1453
Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation
Svennberg E; Stridh M; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Rosenqvist M
Article: HEART. 2017;103(16):1271-1277
N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation
Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
Article: EUROPACE. 2017;19(7):1163-1169
Physicians' knowledge of implantable defibrillator treatment: are we good enough?
Kinch Westerdahl A; Frykman V
Article: THYROID. 2017;27(7):878-885
Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Hoijer J; Lonn S; Torring O
Article: ANNALS OF NONINVASIVE ELECTROCARDIOLOGY. 2017;22(3):e12414
Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure
Sjoblom J; Borgquist R; Gadler F; Kalm T; Ljung L; Rosenqvist M; Frykman V; Platonov PG
Article: EUROPACE. 2017;19(2):297-302
Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design
Engdahl J; Svennberg E; Friberg L; Al-Khalili F; Frykman V; Gudmundsdottir KK; Fredriksson T; Rosenqvist M
Article: EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING. 2017;16(1):57-63
Effects of yoga in patients with paroxysmal atrial fibrillation - a randomized controlled study
Wahlstrom M; Karlsson MR; Medin J; Frykman V
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;222:430-435
Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study
Engdahl J; Holmen A; Svennberg E; Friberg L; Frykman-Kull V; Al-Khalili F; Rosenqvist M; Stromberg U
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2016;50(4):236-242
Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients
Waldenhjort D; Doliwa PS; Alam M; Frykman-Kull V; Engdahl J; Rosenqvist M; Persson H
Article: LAKARTIDNINGEN. 2015;112:DLHL
[Intriguing disease in a new perspective].
Rosenqvist M; Frykman V
Article: EUROPACE. 2015;17(7):1023-1029
Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording
Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman-Kull V; Levin L-A
Article: CIRCULATION. 2015;131(25):2176-2184
Mass Screening for Untreated Atrial Fibrillation The STROKESTOP Study
Svennberg E; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Rosenqvist M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;182:440-446
Defibrillator patients should not be denied a peaceful death
Westerdahl AK; Sutton R; Frykman V
Article: EUROPACE. 2015;17(2):207-214
A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Levin L-A; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T
Article: EUROPACE. 2015;17(2):255-261
Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction
Sjoblom J; Kalm T; Gadler F; Ljung L; Frykman V; Rosenqvist M; Platonov P; Borgquist R
Article: CIRCULATION. 2014;130(9):743-748
Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction Implications for Implantable Cardioverter-Defibrillator Eligibility
Sjoblom J; Muhrbeck J; Witt N; Alam M; Frykman-Kull V
Article: CIRCULATION. 2014;129(4):422-429
Implantable Cardioverter-Defibrillator Therapy Before Death High Risk for Painful Shocks at End of Life
Westerdahl AK; Sjoblom J; Mattiasson A-C; Rosenqvist M; Frykman V
Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 2013;73(7):576-584
Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke
Rooth E; Sobocinski-Doliwa P; Antovic J; Kull VF; Von Arbin M; Rosenqvist M; Wallen H
Article: INTERNATIONAL JOURNAL OF YOGA THERAPY. 2013;23(1):32-53
2013 SYR Accepted Poster Abstracts.
Bayley PJ; Isaac L; Kong JY; Adamson MM; Ashford JW; Mahoney LA; Beltran M; Brown-Elhillali A; Held A; Ajayi A; Belcher H; Bond A; Mason H; Lemaster C; Shaw S; Mullin C; Holick E; Saper R; Braun TD; Riley KE; Park CL; Trehern AE; Davis MB; Mastronardi EL; Butzer B; Khalsa SBS; Shorter SM; Reinhardt KM; Cope S; Cheung C; Justice C; Wyman J; Cook-Cottone CP; Daly LA; Haden SC; Hagins M; Danhauer SC; Griffin LP; Avis NE; Sohl SJ; Lawrence J; Jesse MT; Addington EL; Messino MJ; Giguere JK; Lucas SL; Wiliford SK; Shaw E; de Manincor M; Bensoussan A; Smith C; Fahey P; Bourchier S; Desrochers DIM; Viswanathan S; Partharasathy BR; Doherty K; Moye J; Walsh C; Pokaski-Azar J; Gosian J; Chapman J; King K; Sohl S; Danhauer S; Dunbar E; Gabriel MG; Huebner M; Hofmann SG; Khalsa SBS; Gaskins RB; Jennings E; Thind H; Fava JL; Hartman S; Bock BC; Gramann P; Haaz S; Bingham CO; Bartlett SJ; Hagins M; States R; Selfe T; Innes K; Harris AR; Jennings PA; Abenavoli RM; Katz DA; Hudecek KM; Greenberg MT; Jeter PE; Nkodo AF; Haaz S; Dagnelie G; Keosaian JE; Lemaster CM; Chao M; Saper RB; King KD; Gosian J; Doherty K; Walsh C; Pokaski Azar J; Chapman J; Danhauer SC; Moye J; Kinser P; Bourguignon C; Taylor A; Mahoney LA; Bayley PJ; Collery LM; Menzies-Toman D; Nilsson M; Frykman V; Noggle JJ; Braun T; Khalsa SBS; Nosaka M; Okamura H; Fukatu N; Potts A; Weidknecht K; Coulombe S; Davies B; Ryan C; Day D; Reale J; Staples JK; Knoefel J; Herman C; Riley KE; Park CL; Bedesin EY; Stewart VM; Riley KE; Braun TD; Park CL; Pescatello LS; Davis MB; Trehern AE; Mastronardi EL; Rioux J; Rosen RK; Thind H; Gaskins R; Jennings E; Morrow K; Williams D; Bock B; Rousseau D; Jackson E; Schmid AA; Miller KK; Van Puymbroeck M; Debaun EL; Schalk N; Dierks TD; Altenburger P; Damush T; Williams LS; Selman L; Citron T; Howie-Esquivel J; McDermott K; Milic M; Donesky D; Shook A; Ruzic R; Galloway F; Van Puymbroeck M; Miller KK; Schalk N; Schmid AA; Ward LJ; Stebbings S; Sherman K; Cherkin D; Baxter GD; West JI; Duffy N; Liang B
Article: EUROPACE. 2013;15(1):135-140
Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
Friberg L; Engdahl J; Frykman V; Svennberg E; Levin L-A; Rosenqvist M
Article: EUROPACE. 2012;14(8):1112-1116
Improved screening for silent atrial fibrillation after ischaemic stroke
Sobocinski PD; Rooth EA; Kull VF; von Arbin M; Wallen H; Rosenqvist M
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2012;46(3):144-148
Paroxysmal atrial fibrillation with silent episodes: Intermittent versus continuous monitoring
Doliwa PS; Rosenqvist M; Frykman V
Article: EUROPACE. 2012;14(4):490-495
Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines
Sjoblom J; Ljung L; Frick M; Rosenqvist M; Frykman V
Article: EUROPEAN HEART JOURNAL. 2011;32(18):2282-2289
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA
Wieloch M; Sjalander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
Article: EUROPACE. 2011;13(2):262-269
Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry
Edvardsson N; Frykman V; van Mechelen R; Mitro P; Mohii-Oskarsson A; Pasquie J-L; Ramanna H; Schwertfeger F; Ventura R; Voulgaraki D; Garutti C; Stolt P; Linker NJ
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2009;43(3):163-168
Short-term ECG for out of hospital detection of silent atrial fibrillation episodes
Doliwa PS; Frykman V; Rosenqvist M
Article: LAKARTIDNINGEN. 2006;103(39):2871-2875
[Syncope].
Jemtrén A; Frykman V
Article: PACE - PACING AND CLINICAL ELECTROPHYSIOLOGY. 2003;26(7):1461-1466
Rapid atrial pacing does not decrease the atrial defibrillation threshold
Frykman V; Darpö B; Ayers GM; Bergfeldt L; Linde C; Rosenqvist M
Article: AMERICAN HEART JOURNAL. 2003;145(4):670-675
What characterizes episodes of atrial fibrillation requiring cardioversion?: Experience from patients with an implantable atrial cardioverter
Frykman V; Ayers GM; Darpö B; Rosenqvist M
Article: JOURNAL OF INTERNAL MEDICINE. 2003;253(1):76-80
Duration of warfarin sodium therapy prior to electrical cardioversion of atrial fibrillation
Ryman J; Frick M; Frykman V; Rosenqvist M
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):390-397
Asymptomatic versus symptomatic persistent atrial fibrillation:: clinical and noninvasive characteristics
Frykman V; Frick M; Jensen-Urstad M; Östergren J; Rosenqvist M
Article: EUROPEAN HEART JOURNAL. 2001;22(20):1954-1959
Management of atrial fibrillation:: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications
Frykman V; Beerman B; Rydén L; Rosenqvist M
Article: CLINICAL CARDIOLOGY. 2001;24(3):238-244
Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation
Frick M; Frykman V; Jensen-Urstad M; Östergren J; Rosenqvist M
Visa fler

Alla övriga publikationer

Review: LAKARTIDNINGEN. 2015;112:DI7R
[The Swedish National Board of Health and Welfare provides new cardiology guidelines during the autumn].
Frykman V
Letter: LAKARTIDNINGEN. 2009;106(50-51):3442
[Prednisolone affects Waran medication].
Holmström B; Johnsson H; Frykman V
Thesis / dissertation: 2002
Atrial fibrillation : clinical managements with special emphasis on cardioversion
Frykman, Viveka
Letter: JOURNAL OF INTERNAL MEDICINE. 2002;251(4):365
Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics - Reply
Frykman V

Anställningar

Anknuten till Forskning, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2026

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Solna, Karolinska Institutet, 2002

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI